Evidence map›Paper›PMID 29143163›Full record

ArticleAIDS and behavior2018

Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.

Julie Franks, Yael Hirsch-Moverman, Avelino S Loquere, K Rivet Amico, Robert M Grant, Bonnie J Dye, Yan Rivera, Robert Gamboa, Sharon B Mannheimer

Abstract read
In one paragraph

Article in AIDS and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pre-Exposure Prophylaxis Interventions among Black Sexual Minority Men: A Systematic Literature Review.International journal of environmental research and public health · 2022
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. [HIV self-testing strategy: implementation in Latin America and Mexico. Where are we going].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julie FranksICAP at Columbia University, Harlem Prevention Center, 215 W. 125th St., Suite A, New York, NY, 10027, USA. jf642@cumc.columbia.edu.ORCID 0000-0001-6329-2301
Yael Hirsch-MovermanICAP at Columbia University, Harlem Prevention Center, 215 W. 125th St., Suite A, New York, NY, 10027, USA.
Avelino S LoquereICAP at Columbia University, Harlem Prevention Center, 215 W. 125th St., Suite A, New York, NY, 10027, USA.
K Rivet AmicoDepartment of Health Behavior and Health Education, University of Michigan, Ann Arbor, MI, USA.
Robert M GrantGladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.
Bonnie J DyeFHI 360, Durham, NC, USA.
Yan RiveraICAP at Columbia University, Harlem Prevention Center, 215 W. 125th St., Suite A, New York, NY, 10027, USA.
Robert GamboaICAP at Columbia University, Harlem Prevention Center, 215 W. 125th St., Suite A, New York, NY, 10027, USA.
Sharon B MannheimerICAP at Columbia University, Harlem Prevention Center, 215 W. 125th St., Suite A, New York, NY, 10027, USA.

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI MYRON Scott COHEN, Sinead Delany-Moretlwe · 2011 to 2026
$779.5M
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
Chemoprophylaxis and HIV Host InteractionsR01AI118575 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANT, ROBERT M. · 2015 to 2019
$2.9M
NIAID NIH HHS R01 AI118575NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069470
6 · The paper itself

Abstract

The HPTN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT) study evaluated daily and non-daily dosing schedules for oral pre-exposure prophylaxis (PrEP) to prevent HIV. A qualitative sub-study including focus groups and in-depth interviews was conducted among men who have sex with men participating in New York City to understand their experience with PrEP and study dosing schedules. The 37 sub-study participants were 68% black, 11% white, and 8% Asian; 27% were of Hispanic/Latino ethnicity. Mean age was 34 years. Themes resulting from qualitative analysis include: PrEP is a significant advance for HIV prevention; non-daily dosing of PrEP is congruent with HIV risk; and pervasive stigma connected to HIV and risk behavior is a barrier to PrEP adherence, especially for non-daily dosing schedules. The findings underscore how PrEP intersects with other HIV prevention practices and highlight the need to understand and address multidimensional stigma related to PrEP use.

Indexed as

Pre-Exposure ProphylaxisSocial StigmaAdultAnti-HIV AgentsEthnicityFocus GroupsHIV InfectionsHomosexuality, MaleHumansMaleMedication AdherenceMiddle AgedNew York CityQualitative ResearchRisk-TakingSafe SexAnti-HIV AgentsAdherenceMSMPre-exposure prophylaxisSexual behaviorStigma

Identifiers

PMID29143163
PMCPMC5878834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.